ALKS
Price
$24.68
Change
+$0.24 (+0.98%)
Updated
Apr 26, 6:59 PM EST
3 days until earnings call
VTRS
Price
$11.57
Change
+$0.10 (+0.87%)
Updated
Apr 26, 6:59 PM EST
11 days until earnings call
Ad is loading...

Compare trend and price ALKS vs VTRS

Header iconALKS vs VTRS Comparison
Open Charts ALKS vs VTRSBanner chart's image
Alkermes
Price$24.68
Change+$0.24 (+0.98%)
Volume$561.86K
CapitalizationN/A
Viatris
Price$11.57
Change+$0.10 (+0.87%)
Volume$2.18M
CapitalizationN/A
View a ticker or compare two or three
ALKS vs VTRS Comparison Chart

Loading...

ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALKS vs. VTRS commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and VTRS is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (ALKS: $24.68 vs. VTRS: $11.57)
Brand notoriety: ALKS and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 52% vs. VTRS: 60%
Market capitalization -- ALKS: $4.55B vs. VTRS: $14.18B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • ALKS’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than ALKS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • ALKS’s TA Score: 6 bullish, 3 bearish.
  • VTRS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ALKS is a better buy in the short-term than VTRS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +3.48% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +2.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.25%. For the same industry, the average monthly price growth was +25.83%, and the average quarterly price growth was +18833.95%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 24, 2024.

VTRS is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-0.25% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for ALKS with price predictions.
OPEN
A.I.dvisor published
a Summary for VTRS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than ALKS($4.55B). VTRS has higher P/E ratio than ALKS: VTRS (238.80) vs ALKS (8.90). VTRS YTD gains are higher at: 7.883 vs. ALKS (-11.031). VTRS has higher annual earnings (EBITDA): 3.52B vs. ALKS (519M). VTRS has more cash in the bank: 1.18B vs. ALKS (773M). ALKS has less debt than VTRS: ALKS (372M) vs VTRS (18.4B). VTRS has higher revenues than ALKS: VTRS (15.4B) vs ALKS (1.66B).
ALKSVTRSALKS / VTRS
Capitalization4.55B14.2B32%
EBITDA519M3.52B15%
Gain YTD-11.0317.883-140%
P/E Ratio8.90238.804%
Revenue1.66B15.4B11%
Total Cash773M1.18B65%
Total Debt372M18.4B2%
FUNDAMENTALS RATINGS
ALKS vs VTRS: Fundamental Ratings
ALKS
VTRS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3289
PRICE GROWTH RATING
1..100
6146
P/E GROWTH RATING
1..100
981
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (18) in the null industry is significantly better than the same rating for ALKS (99) in the Biotechnology industry. This means that VTRS’s stock grew significantly faster than ALKS’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as ALKS (100) in the Biotechnology industry. This means that VTRS’s stock grew similarly to ALKS’s over the last 12 months.

ALKS's SMR Rating (32) in the Biotechnology industry is somewhat better than the same rating for VTRS (89) in the null industry. This means that ALKS’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (46) in the null industry is in the same range as ALKS (61) in the Biotechnology industry. This means that VTRS’s stock grew similarly to ALKS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for ALKS (98) in the Biotechnology industry. This means that VTRS’s stock grew significantly faster than ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSVTRS
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 13 days ago
67%
Bearish Trend 12 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
61%
View a ticker or compare two or three
Ad is loading...
ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URNJ25.560.49
+1.95%
Sprott Junior Uranium Miners ETF
BWEB43.650.76
+1.77%
Bitwise Web3 ETF
EWA23.720.14
+0.59%
iShares MSCI Australia ETF
DIVS26.650.11
+0.41%
SmartETFs Dividend Builder ETF
PZT22.580.02
+0.11%
Invesco New York AMT-Free Muni Bd ETF

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with VTRS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+0.98%
VTRS - ALKS
34%
Loosely correlated
+0.87%
ACET - ALKS
30%
Poorly correlated
-7.18%
DCPH - ALKS
28%
Poorly correlated
+3.31%
ITCI - ALKS
26%
Poorly correlated
+1.57%
PAHC - ALKS
25%
Poorly correlated
+2.33%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with PRGO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.87%
PRGO - VTRS
40%
Loosely correlated
+2.14%
TEVA - VTRS
38%
Loosely correlated
+4.23%
ELAN - VTRS
37%
Loosely correlated
+1.69%
ALKS - VTRS
34%
Loosely correlated
+0.98%
PAHC - VTRS
32%
Poorly correlated
+2.33%
More